Most Recent
A court has issued an order restraining US blockchain company Ripple Labs from advertising its PayID system to Aussies, two days after the company agreed to geoblock its website within Australia.
US blockchain technology firm Ripple Labs has said that it will rebrand and block access to allegedly infringing websites as it seeks to rapidly resolve an intellectual property dispute launched over the PayID trade mark.
The company behind the ubiquitous mobile banking PayID system has filed Federal Court trade mark proceedings against a US blockchain technology firm over its global real-time payment service.
Consumer goods giant Procter & Gamble has dropped a lawsuit accusing competitor Colgate-Palmolive of breaching consumer laws by making false claims about the performance of its whitening toothpaste that threatened to push its own brand of whitener off the shelves.
Tile maker Ceramiche Caesar has prevailed in its challenge to a judge's ruling allowing building products manufacturer Caesarstone to register two trade marks despite a finding that they were deceptively similar to one of its marks.
IP Australia has appealed a judge's decision to allow four Aristocrat gaming patents to proceed to grant, hoping for another victory after winning two high stakes challenges to software patents before the Full Federal Court.
Personal care giant Procter & Gamble has told a court that some of its Oral B teeth whitening products may be taken off retailer’s shelves if its lawsuit, which alleges competitor Colgate-Palmolive made misleading claims that its whitening toothpaste can remove 10 years of stains, is not expedited.
A judge has trimmed the costs the Commissioner of Patents owes Aristocrat Technologies after the gaming giant successfully appealed a ruling rejecting four of its gaming patents, saying Aristocrat had "over-egged the pudding" by submitting evidence from three experts on the patentability of its inventions.
Telstra has been ordered to provide technology company Siemens Industry Software with all documents relating to the identity of account holders who may have infringed Siemens’ copyright.
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract "incorporeal" genetic information that is naturally found within the DNA of an unborn foetus.